Effects of Sleep Restriction on BAT Activation in Humans
BAT
1 other identifier
interventional
4
1 country
1
Brief Summary
The goal of this proposed research is to test the hypothesis that long-term mild sleep restriction (SR), as occurs frequently in adults and adolescents, leads to a positive energy balance and weight gain. Aim 1. To determine the effects of SR, relative to habitual sleep (HS), on food choice and energy intake (EI) in adults at risk of obesity.
- Hypothesis 1a. EI, assessed by multiple weekly 24-hour recalls, will be greater during a period of SR relative to HS. This will be mostly due to increased fat and carbohydrate intakes.
- Hypothesis 1b. Neuronal responses to food stimuli, assessed by functional MRI (fMRI) after 6 weeks of SR or HS, will indicate increased activity in networks associated with reward and food valuation (insula, orbitofrontal cortex) during a period of SR relative to HS. These responses will be correlated with intakes of high carbohydrate and high fat foods (hypothesis 1a) and neuropeptide Y (NPY). Moreover, activation of the default mode network (DMN) will be suppressed to a lesser extent after SR compared to HS. Aim 2. To determine the effects of SR, relative to HS, on energy expenditure (EE) via independent and complementary approaches.
- Hypothesis 2a. EE, assessed by doubly-labeled water (DLW), and physical activity level, monitored daily by actigraphy, will be lower during SR relative to HS.
- Hypothesis 2b. Brown adipose tissue (BAT), assessed by positron emission tomography and magnetic resonance combined scanner (PET/MR) using 18F-fluorodeoxyglucose (18FDG-PET) and fat fraction (FF) measurement under cold stimulation, will be greater after SR relative to HS. This would suggest higher adaptive thermogenesis after SR compared to HS. BAT activation will also be correlated with NPY. Aim 3. To determine whether SR alters body weight and adiposity relative to HS.
- Hypothesis 3a. SR will lead to weight gain and increased total adiposity, as assessed using magnetic resonance imaging (MRI), relative to HS.
- Hypothesis 3b. Increased adiposity after SR will be correlated to an adverse cardio-metabolic risk profile (increased glucose, insulin, triglycerides, leptin, reduced high-density lipoprotein cholesterol and adiponectin) and neuronal responses to food stimuli (Hypothesis 1b), and EE (Hypothesis 2a \& 2b). Failure to stimulate BAT with SR will be associated with greater gain in adiposity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
February 10, 2016
CompletedFirst Posted
Study publicly available on registry
May 12, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedJuly 19, 2017
July 1, 2017
1.4 years
February 10, 2016
July 17, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline Brown adipose tissue (BAT) in 6 weeks
Assessed by positron emission tomography and magnetic resonance combined scanner (PET/MR) using 18F-fluorodeoxyglucose (18FDG-PET). Fat fraction (FF) measurement under cold stimulation is to be measured.
6 weeks
Secondary Outcomes (2)
Difference in weight from baseline at 6 weeks
6 weeks
Difference in Glucose level from baseline at 6 weeks
6 weeks
Study Arms (2)
PSR-TSD
EXPERIMENTALPartial sleep restriction (PSR) followed by total sleep deprivation (TSD). Experimental procedures will begin with a 3-day period of habitual sleep (HS).
TSD-PSR
EXPERIMENTALTotal sleep deprivation (TSD) followed by partial sleep restriction (PSR). Experimental procedures will begin with a 3-day period of habitual sleep (HS).
Interventions
4 hour time in bed (TIB), participants will go to bed 4 hours later than during the HS condition. Wake-up times will be the same. During the in-lab portion of the PSR, meals, fulfilling weight-maintenance energy requirements, will be supplied by the research staff as BOOST shakes.
0 hour time in bed (TIB), participants will remain awake throughout the night. Meals will be provided as BOOST shakes at the same meal.
8 hours time in bed (TIB), for 3 nights, with fixed bed and wake times, while at home. During the 3-d HS phase, participants will be provided will BOOST meal replacement shakes in amounts required to achieve weight maintenance.
Eligibility Criteria
You may qualify if:
- Normal scores on:
- Pittsburgh Quality of Sleep Questionnaire
- Epworth Sleepiness Scale
- Berlin Questionnaire
- Sleep Disorders Inventory Questionnaire
- Beck Depression Inventory
- Composite Scale of Morningness/Eveningness
- Three Factor Eating Questionnaire
- Sleep 7-9 hours in bed/night with no daytime nap
- Age 20-49 years, premenopausal women
- All racial/ethnic groups
- Body mass index 25-29.9 kg/m2
You may not qualify if:
- Smokers (any cigarettes or ex-smoker \<3 years)
- Neurological, medical or psychiatric disorder, diabetics
- Eating and/or sleep disorders
- Contraindications for MRI scanning
- Travel across time zones within 4 weeks
- History of drug and alcohol abuse
- Shift worker (or rotating shift worker)
- Caffeine intake \>300 mg/d
- Pregnancy or within 1 y post-partum
- Heavy equipment operators Commercial long-distance drivers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Columbia Universitylead
- New York Universitycollaborator
Study Sites (1)
New York Nutrition Obesity Research Center
New York, New York, 10032, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marie-Pierre St-Onge, Ph.D
Assistant Professor of Nutritional Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Nutritional Medicine, Dept of Medicine Endocrinology
Study Record Dates
First Submitted
February 10, 2016
First Posted
May 12, 2016
Study Start
January 1, 2016
Primary Completion
June 1, 2017
Study Completion
July 1, 2017
Last Updated
July 19, 2017
Record last verified: 2017-07
Data Sharing
- IPD Sharing
- Will not share